Mycobacterium abscessus from respiratory isolates: activities of drug combinations

被引：23

作者：

Cremades, Rosa ^{[1
,2
,3
]}

Santos, Ana ^{[1
,2
,3
]}

Carlos Rodriguez, Juan ^{[1
,2
,3
]}

Garcia-Pachon, Eduardo ^{[1
,2
,3
]}

Ruiz, Montserrat ^{[1
,2
,3
]}

Royo, Gloria ^{[1
,2
,3
]}

机构：

[1] Hosp Gen Univ Elche, Microbiol Sect, Elche 03203, Spain

[2] Hosp Gen Univ Elche, Sect Pneumol, Elche 03203, Spain

[3] Univ Miguel Hernandez, Elche, Spain

来源：

JOURNAL OF INFECTION AND CHEMOTHERAPY | 2009年 / 15卷 / 01期

关键词：

Mycobacterium abscessus; Combination effect; Clarithromycin; Antimicrobial susceptibility; Fluoroquinolones; Macrolides; Linezolid; RAPIDLY GROWING MYCOBACTERIA; BACTERICIDAL ACTIVITY; CLARITHROMYCIN; RESISTANCE;

D O I：

10.1007/s10156-008-0651-y

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Mycobacterium abscessus is the most resistant of rapidly growing pathogenic mycobacteria. We performed a screening of the in vitro sterilizing capacity of various antibiotic combinations against two strains isolated from respiratory samples (in vitro activity of each antibiotic: 51 combinations of two drugs and 47 of three drugs). Our findings confirm that clarithromycin is the most useful drug. The combination of this drug with linezolid exhibits good activity. In addition, the fluoroquinolones and rifabutin in association with clarithromycin may have clinical utility because they are administered orally. Therapeutic alternatives in this type of infections should be evaluated in greater depth.

引用

页码：46 / 48

页数：3

共 14 条

[1]

Brown-Elliott BA, 2001, J CLIN MICROBIOL, V39, P2745, DOI 10.1128/JCM.39.7.2745-2746.2001

[2] Intrapulmonary pharmacokinetics of linezolid [J].